StockWatch
·
Biotechnology: Pharmaceutical Preparations
Management ChangeOct 2, 2026, 04:21 PM

Prothena Chief Development Officer Chad Swanson Resigns

AI Summary

Prothena Corporation plc announced that its Chief Development Officer, Chad J. Swanson, Ph.D., has resigned from his position. His resignation is effective October 9, 2026. Dr. Swanson is departing to take on a leadership role within a program partnered with Prothena at one of the company's strategic partners.

Key Highlights

  • Chad J. Swanson, Ph.D., Chief Development Officer of Prothena Corporation plc, has resigned.
  • Dr. Swanson's resignation is effective October 9, 2026.
  • He is leaving to accept a leadership role over a partnered program at one of Prothena's strategic partners.